NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 54 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,000 | +33.3% | 26,000 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 26,000 | +23.8% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 21,000 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | +150.0% | 21,000 | +670.4% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 2,726 | -0.8% | 0.00% | – |
| Q2 2016 | $1,000 | -100.0% | 2,749 | -99.8% | 0.00% | -100.0% |
| Q3 2013 | $4,627,000 | -12.0% | 1,745,871 | -11.3% | 0.00% | -50.0% |
| Q2 2013 | $5,257,000 | – | 1,968,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|